Compared to the placebo, patients treated with Kisunla had a 35% slower cognitive and functional decline at 18 months of ...

Alzheimer’s drug, donanemab (marketed as Kisunla), could be rejected for use by the National Health Service (NHS) in Britain, ...

What is the new drug recently approved by the FDA for Alzheimer’s disease? In July, the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) for the treatment of people living ...

Several Alzheimer’s patients in Fresno became some of the first in the nation to receive a new drug just approved by the FDA.

FRESNO, Calif. (KFSN) -- A long-time Fresno doctor is part of a ground-breaking treatment in the fight against Alzheimer's.

Several people in fresno were among the first in the nation to receive a new treatment for alzheimer's disease.Now patients ...

As quantitative data replaced qualitative descriptions in the ads, and as information about severe adverse effects was ...

Eli Lilly recently obtained approval for an early Alzheimer's treatment, Kisunla. Biogen's Leqembi was approved last year, and a recent study confirmed its long-term benefits. These companies have ...

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. Kisunla is given as an intravenous (IV) infusion by a doctor or other healthcare professional.

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. This drug currently isn’t known to interact with other drugs. Note: As a person’s ...

(KSEE/KGPE) — Several Alzheimer’s patients in Fresno, California became some of the first in the nation to receive a new drug just approved by the FDA. Doctors said the drug Kisunla is the ...